- Patent Title: Methods of treating RBP4 related diseases with triazolopyridines
-
Application No.: US17228590Application Date: 2021-04-12
-
Publication No.: US12016853B2Publication Date: 2024-06-25
- Inventor: Yu-Hsin Tom Lin , Cheng-Chi Irene Wang , Konstantin Petrukhin
- Applicant: Belite Bio, Inc , THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
- Applicant Address: KY NY Cayman Island
- Assignee: Belite Bio, Inc,The Trustees of Columbia University in the City of New York
- Current Assignee: Belite Bio, Inc,The Trustees of Columbia University in the City of New York
- Current Assignee Address: KY Grand Cayman; US NY New York
- Agency: Wilson Sonsini Goodrich & Rosati
- The original application number of the division: US16272911 2019.02.11
- Main IPC: A61K31/4545
- IPC: A61K31/4545 ; A61K9/00 ; A61K31/4985 ; A61K31/519 ; A61K31/5365 ; A61K31/5383 ; A61P3/04 ; A61P3/10
Abstract:
Provided herein are heterocyclic derivative compounds and pharmaceutical compositions comprising said compounds that are useful for the treatment of retinal binding protein (RBP4) related diseases, such as obesity and the like.
Public/Granted literature
- US11980614B2 Methods of treating RBP4 related diseases with triazolopyridines Public/Granted day:2024-05-14
Information query
IPC分类:
